KOREA UNITED PHARM, INC. (033270) Price & Analysis

― Followers

033270 Stock Chart & Stats

₩17780.00

-₩100.00(-0.56%)

Aug 05, 2026

―

Day’s Range― - ―

52-Week Range₩16,100.00 - ₩21,800.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)27.80K

Market Cap

₩258.99B

Enterprise Value₩158.55K

Total Cash (Recent Filing)₩171.65B

Total Debt (Recent Filing)₩13.32B

Price to Earnings (P/E)6.8

Beta0.11

Next Earnings

Nov 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)2633.27

Shares Outstanding15,910,775

10 Day Avg. Volume28,720

30 Day Avg. Volume27,803

Financial Highlights & Ratios

PEG Ratio0.39

Price to Book (P/B)0.69

Price to Sales (P/S)1.08

P/FCF Ratio11.25

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

033270 FAQ

What was KOREA UNITED PHARM, INC.’s price range in the past 12 months?

KOREA UNITED PHARM, INC. lowest stock price was ₩16100.00 and its highest was ₩21800.00 in the past 12 months.

What is KOREA UNITED PHARM, INC.’s market cap?

KOREA UNITED PHARM, INC.’s market cap is ₩258.99B.

When is KOREA UNITED PHARM, INC.’s upcoming earnings report date?

KOREA UNITED PHARM, INC.’s upcoming earnings report date is Nov 18, 2026 which is in 104 days.

How were KOREA UNITED PHARM, INC.’s earnings last quarter?

KOREA UNITED PHARM, INC. released its earnings results on Jul 30, 2026. The company reported ₩2369.84 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is KOREA UNITED PHARM, INC. overvalued?

According to Wall Street analysts KOREA UNITED PHARM, INC.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does KOREA UNITED PHARM, INC. pay dividends?

KOREA UNITED PHARM, INC. does not currently pay dividends.

What is KOREA UNITED PHARM, INC.’s EPS estimate?

KOREA UNITED PHARM, INC.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does KOREA UNITED PHARM, INC. have?

KOREA UNITED PHARM, INC. has 15,910,775 shares outstanding.

What happened to KOREA UNITED PHARM, INC.’s price movement after its last earnings report?

KOREA UNITED PHARM, INC. reported an EPS of ₩2369.84 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.459%.

Which hedge fund is a major shareholder of KOREA UNITED PHARM, INC.?

Currently, no hedge funds are holding shares in KR:033270

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

KOREA UNITED PHARM, INC.

Korea United Pharm Inc. is a South Korean enterprise dedicated to the development, production, and distribution of a wide array of pharmaceutical products. The company's extensive portfolio encompasses therapeutic solutions for various medical fields, such as the respiratory, musculoskeletal, gastrointestinal, cardiovascular, and central nervous systems, in addition to treatments for cancer, infections, allergies, and immune disorders. It also supplies over-the-counter drugs. While deeply rooted in the South Korean market, the firm extends its reach internationally, exporting its medications to nearly 40 countries. Founded in 1987, Korea United Pharm Inc. is headquartered in Seoul, South Korea.